检索结果 - Yoshimasa Kosaka
- Showing 1 - 2 results of 2
-
1
Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphami... 由 Yoshimasa Kosaka, Yoshiaki Rai, Norikazu Masuda, Toshimi Takano, Toshiaki Saeki, Seigo Nakamura, Ryutaro Shimazaki, Yoshinori Ito, Yutaka Tokuda, Kazuo Tamura
出版 2015Artigo -
2
Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer 由 Jonathan T. Lei, Jieya Shao, Jin Zhang, Michael D. Iglesia, Doug W. Chan, Jin Cao, Meenakshi Anurag, Purba Singh, Xiaping He, Yoshimasa Kosaka, Ryoichi Matsunuma, Robert J. Crowder, Jeremy Hoog, Chanpheng Phommaly, Rodrigo Gonçalves, Susana Ramalho, Raquel Mary Rodrigues Peres, Nindo Punturi, Cheryl Schmidt, Alex Bartram, Eric Jou, Vaishnavi Devarakonda, Kimberly Holloway, Weiyi Lai, Oliver Hampton, Anna Rogers, Ethan Tobias, Poojan A. Parikh, Sherri R. Davies, Shunqiang Li, X. Cynthia, Vera J. Suman, Kelly K. Hunt, Mark A. Watson, Katherine A. Hoadley, E. Aubrey Thompson, Xi Chen, Shyam M. Kavuri, Chad J. Creighton, Christopher A. Maher, Charles M. Perou, Svasti Haricharan, Matthew J. Ellis
出版 2018Artigo
相关主题
Breast cancer
Cancer
Medicine
Adverse effect
Alternative medicine
Annotation
Bioinformatics
Biology
Cancer research
Chemotherapy
Computational biology
Cyclophosphamide
Docetaxel
Estrogen
Estrogen receptor
Estrogen receptor alpha
Estrogen receptor beta
Febrile neutropenia
Filgrastim
Gene
Genetics
Internal medicine
Neutropenia
Oncology
Pathology
Pegfilgrastim
Placebo
Surgery